Clinical Trial Update: Allogeneic Regulatory Dendritic Cell (DCreg) Renal Study [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update evaluating allogeneic regulatory dendritic cells (DCreg) in kidney transplant recipients. The study status is active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• DCreg (dendritic regulatory cells)

Snippet

Sponsor: Angus W. Thomson PhD DSc | Conditions: Kidney Transplant, Renal Transplant Recipients | Phase 1 | Status: ACTIVE_NOT_RECRUITING